injectable filler

A study has revealed that Botox can make people feel happy because it stops them frowning when they are unhappy. The anti-wrinkle drug sends back the signal to the brain reducing the intensity of the feeling.

Revance Therapeutics says clinical trials of its no-needle Botox-like lotion will be done in about two years. Then the FDA will decide whether to approve the drug, which is used to minimize crow’s feet, WCBS-TV reports.

Wrinkles used to be your only fleeting worry when you ponied up for Botox, but now the cost of your health could be at stake. A surge in the number of misbranded fake versions of Botox have proliferated the market, and law enforcement officials have taken both notice and action, reports the Today Show

Wrinkles used to be your only fleeting worry when you ponied up for Botox, but now the cost of your health could be at stake. A surge in the number of misbranded fake versions of Botox have proliferated the market, and law enforcement officials have taken both notice and action, reports the Today Show.

Merz Aesthetics today announced it is now shipping Asclera™ (polidocanol) Injection sclerotherapy treatment to doctors’ offices throughout the U.S.  Previously only available in Europe, Asclera™ was recently approved by the U.S. Food and Drug Administration (FDA).

Merz Aesthetics today announced it is now shipping Asclera™ (polidocanol) Injection sclerotherapy treatment to doctors’ offices throughout the U.S.  Previously only available in Europe, Asclera™ was recently approved by the U.S. Food and Drug Administration (FDA). In a study published in the June issue of Phlebology, leading experts conclude that polidocanol is a highly effective sclerotherapy treatment.

Shares of obesity drug developers rose Thursday following a report that Arena Pharmaceuticals Inc.’s lorcaserin prompted weight loss without heart-related side effects.On Wednesday, a study showed that lorcaserin caused more people to lose at least 5 percent of their body weight over one year, or more than double the rate of placebo.

Shares of obesity drug developers rose Thursday following a report that Arena Pharmaceuticals Inc.’s lorcaserin prompted weight loss without heart-related side effects.On Wednesday, a study showed that lorcaserin caused more people to lose at least 5 percent of their body weight over one year, or more than double the rate of placebo. The results are in Thursday’s New England Journal of Medicine. The drug is one of three potential blockbusters that could reach the market over the next several years.

A new Health Canada report is warning of complications — including gangrene of the lip in one case — suspected of being associated with the most popular injectable wrinkle fillers on the market.

  The American Society for Aesthetic Plastic Surgery (ASAPS) is proud to introduce Project Beauty , a new consumer website, that will soon become THE beauty site for consumers interested in self-improvement.